GlassScriptPhysician profile
Mabel A Mayorga
NPI 1295115277
$3,022.76
in general payments reported to CMS, 2019-2025
15 companies · $1,623 in 2025
The $1,623 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $523 · 2023: $307 · 2024: $353 · 2025: $1,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612 · Travel and Lodging: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,611.78 |
| Travel and Lodging | $671.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,968.07 | 2022-2025 | Minimed 780g, Endurant Iis, Mycarelink |
| Abbott Laboratories | $309.40 | 2021-2025 | Freestyle Libre |
| Lilly USA, LLC | $177.10 | 2021-2024 | Mounjaro, Zepbound |
| Dexcom, INC. | $160.23 | 2021-2023 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $101.30 | 2022 | |
| Corcept Therapeutics | $78.16 | 2021 | |
| Insulet Corporation | $70.12 | 2023-2025 | Omnipod |
| Janssen Pharmaceuticals, INC | $43.62 | 2022-2023 | Xarelto |
| Heartflow, INC. | $21.17 | 2024 | |
| Baxter Healthcare | $18.94 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Xeris Pharmaceuticals, INC. | $16.64 | 2023 | Gvoke Hypopen |
| Pfizer INC. | $15.30 | 2024 | |
| Azurity Pharmaceuticals, INC. | $14.49 | 2024 | Edarbi |
| Bayer Healthcare Pharmaceuticals INC. | $14.36 | 2022 | |
| Amgen INC. | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mabel Mayorga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.